legislation: 117-s-5316
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117-s-5316 | 117 | s | 5316 | Federal Clarity for Kratom Consumers Act | Health | 2022-12-20 | 2022-12-20 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | Senate | Sen. Lee, Mike [R-UT] | UT | R | L000577 | 1 | Federal Clarity for Kratom Consumers Act This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients. | 2023-08-17T14:15:23Z |